Sumitomo Chemical India Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 10 Jun 2026 | Fertilizers & Agrochemicals | Market Cap: ₹25.3K Cr
FY '27 revenue growth expected to be cautious due to monsoon uncertainty, fertilizer supply, and geopolitical tensions. Sumitomo Chemical India expects volume-driven growth in core agrochemical business post-FY26, with new capex projects (Dahej site INR150 crores+) commercializing from FY28-FY29, adding incremental revenues.
From Sumitomo Chemical India Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹535
Market Cap
₹25.3K Cr
P/E Ratio
44.4
Revenue Rank
Margin Rank
How does Sumitomo Chemical India Ltd rank in Fertilizers & Agrochemicals?
Compare Sumitomo Chemical India Ltd against every Fertilizers & Agrochemicals company this quarter on revenue, margins and earnings-call signals.
Sumitomo Chemical India Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹671 Cr, net profit ₹111 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 4- →FY '27 revenue growth expected to be cautious due to monsoon uncertainty, fertilizer supply, and geopolitical tensions.
- →Current year (FY '27) sales targeted to be maintained around INR110-140 crores in certain segments, with no incremental revenue expected immediately from ongoing capex projects.
- →Incremental revenues from capex at Dahej and other projects anticipated from FY '28 and FY '29 onwards.
- →New product pipeline includes 3-4 molecules; only one (Excalia Max) launched so far with others expected in coming years post regulatory approvals.
- →Specialty products are key growth drivers; contributing to 30% of domestic revenues with new technologies expected to improve volume and revenue mix structurally.
- →Export volumes uncertain in the short term due to global logistics and cost factors but have potential upside if conditions stabilize.
- →Use of India as a manufacturing hub by parent company is expected to drive future capex investments and revenue growth from FY '28 onward.
📈 Profitability & Margins
Rank 3- →Sumitomo Chemical India expects volume-driven growth in core agrochemical business post-FY26, with new capex projects (Dahej site INR150 crores+) commercializing from FY28-FY29, adding incremental revenues.
- →FY27 focus on maintaining current sales levels (INR110-140 crores) with incremental revenue generation expected from next financial year onward.
- →Specialty product mix and new launches (e.g., Lentigo, Excalia Max, Top Grain biostimulant) expected to drive growth and margin expansion.
- →Margin sustainability is a priority; cautious price increases have been implemented to offset rising raw material and freight costs.
- →Parent company plans to use India as a manufacturing hub with significant investments expected, funded largely by accumulated cash in India.
- →R&D capabilities strong internally; no significant additional investments from Japan anticipated.
- →Overall, earnings growth, margin improvement, and EPS growth are expected over the medium term, supported by manufacturing expansions, product mix, and operational discipline.
🏗️ Capital Expenditure Plans
Yes- →Ongoing capex projects are progressing well, especially infrastructure expansion for parent company's proprietary products, including newly launched patented products globally.
- →Commitment to invest in manufacturing expansion at Bhavnagar, Tarapur, and Dahej sites.
- →INR150 crores capex announced for Dahej plant, expected to commercialize within 2 years. Additional phases of similar capex size expected and will be announced periodically over next few years.
- →Company is in advanced stages of techno-commercial feasibility for further capex projects; approvals pending from board and parent company.
- →Capex projects aimed at becoming a manufacturing hub for parent company’s global requirements, including agro intermediates and semiconductor materials.
- →Capex implementation timeline spread over multiple years, with revenue impact expected mostly beyond FY '27.
- →Parent company has confidence in Indian R&D team; no significant capital or manpower transfer from Japan needed for semiconductor chemical initiatives.
- →Large part of future capex to be funded from cash accumulated in India (~INR2,113 crores as of March 2026).
💰 Fundraising & Capital Structure
No information- →The company currently has an essentially debt-free balance sheet.
- →Cash and cash equivalents, including liquid investments, stood at approximately INR 2,113 crores as of March 31, 2026.
- →Capital expenditure (capex) projects are primarily funded through accumulated cash reserves and retained earnings.
- →Net worth increased by 17% year-on-year to INR 3,394 crores, funded entirely through retained earnings.
- →There is no mention of plans for new fundraising through debt or equity in the disclosed call transcript.
- →Future capex projects for manufacturing expansion, including at Dahej, are expected to be funded through internal accruals and cash on hand.
- →The company is maintaining financial discipline and focusing on sustaining profitability without indicating any external funding.
📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Sumitomo Chemical India Ltd Q4 FY26 results?
FY '27 revenue growth expected to be cautious due to monsoon uncertainty, fertilizer supply, and geopolitical tensions. Sumitomo Chemical India expects volume-driven growth in core agrochemical business post-FY26, with new capex projects (Dahej site INR150 crores+) commercializing from FY28-FY29, adding incremental revenues.
What is Sumitomo Chemical India Ltd share price analysis?
Sumitomo Chemical India Ltd currently shows a neutral. The stock trades at a P/E of 44.4 with a market cap of ₹25,334 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sumitomo Chemical India Ltd planning capital expenditure?
Ongoing capex projects are progressing well, especially infrastructure expansion for parent company's proprietary products, including newly launched patented products globally.
Keep Sumitomo Chemical India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.